eli lilly stock retatrutide Stock: Next Stop $2,000? Eli Lilly's Retatrutide Delivers Bariatric-Style

To view or add a comment, sign in The National Council on Patient Information and Education (NCPIE) has designated October as "Talk About Your Medicines" month

When commercial weight management medications are on backorder or unavailable, compounding can provide an alternative

Thus, although an important point to keep attention to, data so far does not indicate that cardiovascular complications are a major cause for concern at the moment (gastrointestinal problems being by far the larger problem experienced by people on GLP1R agonists )

Fertility planning

Retatrutide is primarily recommended for adults with obesity or metabolic conditions who have not achieved sufficient results with diet and exercise alone